Deka Bank Deutsche Girozentrale Teva Pharmaceutical Industries LTD Transaction History

Deka Bank Deutsche Girozentrale

  • $53.9 Billion
  • Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 73,580 shares of TEVA stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,580
Previous 78,319 6.05%
Holding current value
$1.26 Million
Previous $1.26 Million 1.11%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$15.81 - $18.96 $74,923 - $89,851
-4,739 Reduced 6.05%
73,580 $1.28 Million
Q2 2024

Aug 08, 2024
BUY
$12.78 - $17.4 $79,133 - $107,740
6,192 Added 8.58%
78,319 $1.26 Million
Q1 2024

Apr 24, 2024
BUY
$10.67 - $14.43 $44,077 - $59,610
4,131 Added 6.08%
72,127 $1.04 Million
Q4 2023

Jan 24, 2024
BUY
$8.12 - $10.63 $11,164 - $14,616
1,375 Added 2.06%
67,996 $688,000
Q3 2023

Nov 13, 2023
BUY
$7.48 - $10.7 $24,541 - $35,106
3,281 Added 5.18%
66,621 $670,000
Q2 2023

Jul 25, 2023
BUY
$7.2 - $9.47 $126,936 - $166,956
17,630 Added 38.57%
63,340 $477,000
Q1 2023

Apr 24, 2023
BUY
$8.36 - $11.37 $23,558 - $32,040
2,818 Added 6.57%
45,710 $398,000
Q4 2022

Feb 01, 2023
BUY
$7.95 - $9.48 $20,972 - $25,008
2,638 Added 6.55%
42,892 $392,000
Q3 2022

Nov 02, 2022
BUY
$6.86 - $11.95 $17,897 - $31,177
2,609 Added 6.93%
40,254 $307,000
Q2 2022

Aug 03, 2022
BUY
$7.38 - $10.4 $9,645 - $13,592
1,307 Added 3.6%
37,645 $292,000
Q1 2022

Apr 28, 2022
BUY
$7.33 - $9.39 $19,461 - $24,930
2,655 Added 7.88%
36,338 $342,000
Q4 2021

Feb 02, 2022
SELL
$7.9 - $10.19 $955 - $1,232
-121 Reduced 0.36%
33,683 $284,000
Q3 2021

Oct 22, 2021
BUY
$8.38 - $10.18 $37,198 - $45,189
4,439 Added 15.12%
33,804 $329,000
Q2 2021

Aug 05, 2021
BUY
$9.9 - $11.56 $46,183 - $53,927
4,665 Added 18.89%
29,365 $295,000
Q1 2021

Apr 28, 2021
BUY
$10.34 - $12.81 $16,647 - $20,624
1,610 Added 6.97%
24,700 $277,000
Q4 2020

Mar 12, 2021
BUY
$8.61 - $11.04 $8,170 - $10,476
949 Added 4.29%
23,090 $224,000
Q3 2020

Oct 29, 2020
SELL
$8.57 - $12.69 $184,117 - $272,631
-21,484 Reduced 49.25%
22,141 $193,000
Q2 2020

Aug 04, 2020
BUY
$8.12 - $13.12 $21,631 - $34,951
2,664 Added 6.5%
43,625 $524,000
Q1 2020

May 14, 2020
BUY
$6.69 - $13.45 $5,693 - $11,445
851 Added 2.12%
40,961 $360,000
Q4 2019

Feb 04, 2020
SELL
$6.53 - $10.72 $18,662 - $30,637
-2,858 Reduced 6.65%
40,110 $395,000
Q3 2019

Nov 14, 2019
SELL
$6.16 - $9.6 $880,350 - $1.37 Million
-142,914 Reduced 76.88%
42,968 $297,000
Q2 2019

Aug 01, 2019
BUY
$8.12 - $15.72 $632,507 - $1.22 Million
77,895 Added 72.13%
185,882 $1.69 Million
Q1 2019

May 10, 2019
SELL
$15.58 - $20.01 $16,140 - $20,730
-1,036 Reduced 0.95%
107,987 $2.5 Million
Q4 2018

Feb 12, 2019
BUY
$14.59 - $23.84 $15,115 - $24,698
1,036 Added 0.96%
109,023 $1.71 Million
Q3 2018

Nov 09, 2018
SELL
$21.06 - $25.65 $1.09 Million - $1.33 Million
-51,700 Reduced 32.38%
107,987 $0
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $119,067 - $175,441
-7,100 Reduced 4.26%
159,687 $3.95 Million
Q1 2018

May 03, 2018
SELL
$16.68 - $22.07 $2.31 Million - $3.06 Million
-138,469 Reduced 45.36%
166,787 $2.84 Million
Q4 2017

Feb 14, 2018
SELL
$11.23 - $19.1 $45,481 - $77,355
-4,050 Reduced 1.31%
305,256 $5.39 Million
Q3 2017

Nov 06, 2017
BUY
$15.41 - $32.17 $4.77 Million - $9.95 Million
309,306
309,306 $5.46 Million

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
565M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email